Hualan Vac(301207.SZ)

Last Updated 00:00:00
longbridge loading

Hualan Vac: The industry in which the company operates is the human vaccine manufacturing industry, with the main product being the quadrivalent influenza virus vaccine, which is used to prevent influenza caused by the influenza virus. Currently, the company does not have any vaccine products for the prevention of Nipah virus

Wallstreetcn·
SZ
301207
-4.86%
Wallstreetcn·
SZ
301207
-4.86%

Afternoon flu concept shows partial fluctuations, Hualan Vac rises over 10%

Zhitong·
SZ
002007
+0.43%
SZ
301207
-4.86%
Zhitong·
SZ
002007
+0.43%
SZ
301207
-4.86%

Hualan Vac released its performance for the first three quarters, with a net profit attributable to the parent company of 132 million yuan, a decrease of 50.51%

Zhitong·
SZ
301207
-4.86%
Zhitong·
SZ
301207
-4.86%

Overview of A-share dividends and stock distributions: 9 stocks have their equity registration today

Zhitong·
SZ
002007
+0.43%
SZ
301207
-4.86%
Zhitong·
SZ
002007
+0.43%
SZ
301207
-4.86%

Overview of the lifting of restrictions on the circulation of A-shares | August 18

Zhitong·
SZ
301207
-4.86%
SZ
000591
+1.39%
SH
600803
-3.16%
Zhitong·
SZ
301207
-4.86%
SZ
000591
+1.39%
SH
600803
-3.16%

Overview of A-share lock-up stock release: Lock-up stocks worth 46.718 billion yuan are released today

Zhitong·
SH
688728
-5.33%
SZ
301207
-4.86%
Zhitong·
SH
688728
-5.33%
SZ
301207
-4.86%

Next week, 25 stocks will have their restrictions lifted. Based on the latest closing prices, the total market value of the lifted restrictions is 79.529 billion yuan. United Imaging Healthcare will have 231 million shares listed for circulation next week, mainly consisting of original shareholders' restricted shares from the initial public offering, with a market value of 29.541 billion yuan. GCORE's scale of lifted restrictions is second, with 1.05 billion shares listed for circulation next week, primarily consisting of original shareholders' restricted shares from the initial public offering, with a market value of 16.391 billion yuan. In terms of the lifting ratio, Hualan Vac has the highest lifting ratio at 76.37%, followed by Zhongchu Media, GCORE, Luwei Optoelectronics, and Huicheng Co., Ltd

Zhitong·
SH
688728
-5.33%
SZ
301207
-4.86%
SH
688271
+10.09%
Zhitong·
SH
688728
-5.33%
SZ
301207
-4.86%
SH
688271
+10.09%

Hualan Vac: The freeze-dried type B influenza Haemophilus influenzae conjugate vaccine has obtained the drug clinical trial approval notice

Zhitong·
SZ
301207
-4.86%
Zhitong·
SZ
301207
-4.86%

Hualan Vac: Currently focused on the research and production of human vaccines

Zhitong·
SZ
301207
-4.86%
Zhitong·
SZ
301207
-4.86%

Hualan Vac released its first-quarter performance, with a net profit attributable to the parent company of 32.7771 million yuan, a year-on-year decrease of 15.06%

Zhitong·
SZ
301207
-4.86%
Zhitong·
SZ
301207
-4.86%
© 2026 Longbridge｜Disclaimer